glp-1-directed nmda receptor antagonism for obesity treatment Treating using glucagon-like peptide-1-directed N-methyl-D-aspartate inhibition Transforming obesity: The advancement of
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19


















:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)






